ATYPICAL ACUTE DISSEMINATED ENCEPHALOMYELITIS WITH SYSTEMIC INFLAMMATION AFTER A FIRST DOSE OF AZTRAZANECA COVID-19 VACCINE. A CASE REPORT

Atypical acute disseminated encephalomyelitis with systemic inflammation after a first dose of AztraZaneca COVID-19 vaccine. A case report

Atypical acute disseminated encephalomyelitis with systemic inflammation after a first dose of AztraZaneca COVID-19 vaccine. A case report

Blog Article

BackgroundOnly a few cases of University writing acute disseminated encephalomyelitis (ADEM) following coronavirus disease 19 (COVID-19) vaccination have been described since the beginning of the vaccination campaign.ResultsHere we report the first case of central nervous system (CNS) demyelination with systemic inflammatory findings on whole body 19-fluorodeoxyglucose positron emission tomography with computed tomography (FDG-PET/CT) following the ChAdOx1 nCoV-19 Metabolic effects of two high-intensity circuit training protocols: Does sequence matter? vaccine.ConclusionsClinicians should stay aware of potential new adverse events after immunization.

Report this page